AR-ENCAP DIN 02239529
Status: Cancelled (Unreturned Annual)
Holder: THORNE RESEARCH CANADA LTD.
Molecule: XANTHOXYLUM
Available to quote
Health Canada record
| Active ingredient(s) | XANTHOXYLUM 250 MG; BOSWELLIA SERRATA 100 MG; HARPAGOPHYTUM PROCUMBENS 200 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | |
| Class | Human |
| ATC | |
| Original market date | |
| Current status date | 23-Mar-2018 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing XANTHOXYLUM
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 01955063 | XANTHOXYLUM FRAXINEUM GRANULE (1DH-30DH) | HOMEOCAN INC. | Tablet | XANTHOXYLUM 1 DH | Cancelled Post Market |